Author name: Rob Quinn

Rob’s a Marketing leader focused on strengthening marketing competencies, building high-performing teams, and helping companies drive revenue. As VP of Marketing, he is charged with increasing awareness for Claritas Rx solutions and helping support commercial initiatives. For the last 20 years, he has worked within high-tech companies such as The MathWorks, Oracle, Agfa Healthcare, and Bridgehead software offering solutions to the healthcare and life sciences markets. He holds a B.S. degree in Mechanical Engineering from UMASS Lowell and an MBA from UMASS Amherst.

Patient Non-Adherence in Specialty Pharma

Unveiling the Mystery of Patient Non-Adherence in Specialty Pharmaceuticals: A Comprehensive Study

The world of specialty pharmaceuticals consistently brings forth groundbreaking therapies, bringing hope to patients suffering from previously incurable conditions. However, their success heavily depends on patient adherence. An in-depth examination of patient journeys indicates a concerning fact – a sizeable number of patients, prescribed these potentially life-saving specialty drugs, discontinue their treatment plans frequently before their […]

Unveiling the Mystery of Patient Non-Adherence in Specialty Pharmaceuticals: A Comprehensive Study Read More »

Close-up doctor's hand giving pills in blister pack to patient; specialty pharmacy distribution concept

How Will Orphan Drugs Fare in an Era of Rising Costs and Wider Use?

Specialty pharmacy distribution is changing as specialty drug treatments become more commonplace. Many biosimilars have entered the rare disease market, directly competing with biologics like Humira that represented breakthroughs in their time. New treatments for a wide range of conditions are also available, including biologics, cell and gene therapies for rare diseases.  Wider adoption of

How Will Orphan Drugs Fare in an Era of Rising Costs and Wider Use? Read More »